Smartleaf Asset Management’s NeoGenomics NEO Stock Holding History

Smartleaf Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.9K	Sell	1,507 -1,959	-57%	-$20.6K	﹤0.01%	2286
2025 Q4	$42.4K	Buy	3,466 +1,515	+78%	+$16.3K	﹤0.01%	1634
2025 Q3	$15.2K	Sell	1,951 -293	-13%	-$2.05K	﹤0.01%	1933
2025 Q2	$16.1K	Sell	2,244 -418	-16%	-$3.37K	﹤0.01%	1638
2025 Q1	$25.6K	Sell	2,662 -1,494	-36%	-$18.7K	﹤0.01%	1480
2024 Q4	$70.3K	Buy	4,156 +2,787	+204%	+$43.3K	0.01%	1017
2024 Q3	$19.9K	Buy	1,369 +792	+137%	+$12.4K	﹤0.01%	1345
2024 Q2	$7.7K	Buy	577 +295	+105%	+$4.18K	﹤0.01%	1555
2024 Q1	$4.29K	Buy	282 +176	+166%	+$2.72K	﹤0.01%	1268
2023 Q4	$1.78K	Buy	+106	New	+$1.74K	﹤0.01%	979

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Smartleaf Asset Management's NEO Position: Q1 2026 in Review

Smartleaf Asset Management reduced its NeoGenomics (NEO) stake by 57% in Q1 2026, selling an estimated $20.6K and leaving 1,507 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Smartleaf Asset Management first reported a position in NEO in Q4 2023 and has held it in 10 quarters since. The position peaked at $70.3K in Q4 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Smartleaf Asset Management held 1,507 shares of NeoGenomics worth $10.9K as of Q1 2026.
Smartleaf Asset Management sold 1,959 NeoGenomics shares in Q1 2026, an estimated $20.6K.
NeoGenomics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2286 holding.
Smartleaf Asset Management first reported a position in NeoGenomics in Q4 2023 and has held it in 10 quarters since.
Smartleaf Asset Management's NeoGenomics position peaked at $70.3K in Q4 2024.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.